Abstract
It has become anticipated that regenerative medicine will extend into the field of veterinary medicine as new treatments for various disorders. Although the use of allogeneic stem cells for tissue regeneration is more attractive than that of autologous cells in emergencies, the therapeutic potential of allogeneic transplantation is often limited by allo-immune responses inducing graft rejection. Therefore, a methodology for quantifying and monitoring alloreactive T cells is necessary for evaluating allo-immune responses. The mixed lymphocyte reaction (MLR) is widely used to evaluate T cell alloreactivity. In human, flow cytometric MLR with carboxyfluorescein diacetate succinimidyl ester has been established and used as a more useful assay than conventional MLR with radioisotope labeling. However, the available information about alloreactivity based on the differences of dog major histocompatibility complex (MHC) (dog leukocyte antigen, DLA) is quite limited in dog. In this paper, we describe our established flow cytometric MLR method that can quantify the T cell alloreactivity while distinguishing cell phenotypes in dog, and T cell alloreactivity among DLA-type matched pairs was significantly lower than DLA-mismatched pairs, suggesting that our developed flow cytometric MLR method is useful for quantifying T cell alloreactivity. In addition, we demonstrated the advantage of DLA homozygous cells as a donor (stimulator) for allogeneic transplantation. We also elucidated that the frequency of alloreactive T cell precursors was almost the same as that of mouse and human (1–10%). To our knowledge, this is the first report to focus on the degree of allo-immune responses in dog based on the differences of DLA polymorphisms.
Similar content being viewed by others
References
Adachi K, Kano Y, Nagai T, Okuyama N, Sakoda Y, Tamada K (2018) IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor. Nat Biotechnol 36:346–351
Adin CA, Gilor C (2017) Focus: Comparative medicine: the diabetic dog as a translational model for human islet transplantation. Yale J Biol Med 90:509
Aggarwal S, Pittenger MF (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815–1822
Ali JM, Bolton EM, Bradley JA, Pettigrew GJ (2013) Allorecognition pathways in transplant rejection and tolerance. Transplantation 96:681–688
Arinzeh TL, Peter SJ, Archambault MP, Van Den Bos C, Gordon S, Kraus K, Smith A, Kadiyala S (2003) Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect. JBJS 85:1927–1935
Bach FC, Willems N, Penning LC, Ito K, Meij BP, Tryfonidou MA (2014) Potential regenerative treatment strategies for intervertebral disc degeneration in dogs. BMC Vet Res 10:3
Beggs KJ, Lyubimov A, Borneman JN, Bartholomew A, Moseley A, Dodds R, Archambault MP, Smith AK, McIntosh KR (2006) Immunologic consequences of multiple, high-dose administration of allogeneic mesenchymal stem cells to baboons. Cell Transplant 15:711–721
Black LL, Gaynor J, Gahring D, Adams C, Aron D, Harman S, Gingerich DA, Harman R (2007) Effect of adipose-derived mesenchymal stem and regenerative cells on lameness in dogs with chronic osteoarthritis of the coxofemoral joints: a randomized, double-blinded, multicenter controlled trial. Vet Ther 8:272
Bøyum A, Løvhaug D, Tresland L, Nordlie E (1991) Separation of leucocytes: improved cell purity by fine adjustments of gradient medium density and osmolality. Scand J Immunol 34:697–712
Burnett RC, Geraghty DE (1995) Structure and expression of a divergent canine class I gene. J Immunol 155:4278–4285
Burnett R, DeRose S, Wagner J, Store R (1997) Molecular analysis of six dog leukocyte antigen class I sequences including three complete genes, two truncated genes and one full-length processed gene. Tissue Antigens 49:484–495
Ciurea SO, Thall PF, Wang X, Wang SA, Hu Y, Cano P, Aung F, Rondon G, Molldrem JJ, Korbling M, Shpall EJ, de Lima M, Champlin RE, Fernandez-Vina M (2011) Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation. Blood 118(22):5957–5964
Debenham SL, Hart EA, Ashurst JL, Howe KL, Quail MA, Ollier WE, Binns MM (2005) Genomic sequence of the class II region of the canine MHC: comparison with the MHC of other mammalian species. Genomics 85:48–59
Eliopoulos N, Stagg J, Lejeune L, Pommey S, Galipeau J (2005) Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice. Blood 106:4057–4065
Graumann M, DeRose S, Ostrander E, Storb R (1998) Polymorphism analysis of four canine MHC class I genes. Tissue Antigens 51:374–381
Hall M, Rosenkrantz WS, Hong J, Griffin CE, Mendelsohn C (2010) Evaluation of the potential use of adipose-derived mesenchymal stromal cells in the treatment of canine atopic dermatitis: a pilot study. Vet Ther 11:1–14
Heemskerk M, Cornelissen J, Roelen D, Van Rood J, Claas F, Doxiadis I, Oudshoorn M (2007) Highly diverged MHC class I mismatches are acceptable for haematopoietic stem cell transplantation. Bone Marrow Transplant 40:193
Isakova IA, Lanclos C, Bruhn J, Kuroda MJ, Baker KC, Krishnappa V, Phinney DG (2014) Allo-reactivity of mesenchymal stem cells in rhesus macaques is dose and haplotype dependent and limits durable cell engraftment in vivo. PLoS One 9:e87238
Jansson M, Laikre L (2018) Pedigree data indicate rapid inbreeding and loss of genetic diversity within populations of native, traditional dog breeds of conservation concern. PLoS One 13:e0202849
Jung DI, Ha J, Kang BT, Kim JW, Quan FS, Lee JH, Woo EJ, Park HM (2009) A comparison of autologous and allogenic bone marrow-derived mesenchymal stem cell transplantation in canine spinal cord injury. J Neurol Sci 285:67–77
Kaeberlein M, Creevy KE, Promislow DE (2016) The dog aging project: translational geroscience in companion animals. Mamm Genome 27:279–288
Kennedy L, Barnes A, Short A, Brown J, Lester S, Seddon J, Fleeman L, Francino O, Brkljacic M, Knyazev S (2007) Canine DLA diversity: 1. New alleles and haplotypes. Tissue Antigens 69:272–288
Kim JW, Lee JH, Lyoo YS, Jung DI, Park HM (2013) The effects of topical mesenchymal stem cell transplantation in canine experimental cutaneous wounds. Vet Dermatol 24:242–e53
Kreijveld E, Koenen HJ, van Cranenbroek B, van Rijssen E, Joosten I, Hilbrands LB (2008) Immunological monitoring of renal transplant recipients to predict acute allograft rejection following the discontinuation of tacrolimus. PLoS One 3:e2711
Leroy G, Phocas F, Hedan B, Verrier E, Rognon X (2015) Inbreeding impact on litter size and survival in selected canine breeds. Vet J 203:74–78
Lewis TW, Abhayaratne BM, Blott SC (2015) Trends in genetic diversity for all Kennel Club registered pedigree dog breeds. Canine Genet Epidemiol 2:13
Liu H, Kemeny DM, Heng BC, Ouyang HW, Melendez AJ, Cao T (2006) The immunogenicity and immunomodulatory function of osteogenic cells differentiated from mesenchymal stem cells. J Immunol 176:2864–2871
Liu G, Zhang Y, Liu B, Sun J, Li W, Cui L (2013) Bone regeneration in a canine cranial model using allogeneic adipose derived stem cells and coral scaffold. Biomaterials 34:2655–2664
Lyons AB (2000) Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J Immunol Methods 243:147–154
Miyamae J, Suzuki S, Katakura F, Uno S, Tanaka M, Okano M, Matsumoto T, Kulski JK, Moritomo T, Shiina T (2018) Identification of novel polymorphisms and two distinct haplotype structures in dog leukocyte antigen class I genes: DLA-88, DLA-12 and DLA-64. Immunogenetics 70:237–255
Nakatsuji N, Nakajima F, Tokunaga K (2008) HLA-haplotype banking and iPS cells. Nat Biotechnol 26:739
Noorchashm H, Lieu YK, Rostami SY, Song HK, Greeley SA, Bazel S, Barker CF, Naji A (1999) A direct method for the calculation of alloreactive CD4+ T cell precursor frequency1. Transplantation 67:1281–1284
Pedersen NC, Brucker L, Tessier NG, Liu H, Penedo MC, Hughes S, Oberbauer A, Sacks B (2015) The effect of genetic bottlenecks and inbreeding on the incidence of two major autoimmune diseases in standard poodles, sebaceous adenitis and Addison’s disease. Canine Genet Epidemiol 2:14
Pezzanite LM, Fortier LA, Antczak DF, Cassano JM, Brosnahan MM, Miller D, Schnabel LV (2015) Equine allogeneic bone marrow-derived mesenchymal stromal cells elicit antibody responses in vivo. Stem Cell Res Ther 6:54
Poncelet AJ, Vercruysse J, Saliez A, Gianello P (2007) Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo. Transplantation 83:783–790
Raff RF, Storb R, Ladiges WC, Deeg HJ (1985) Recognition of target cell determinants associated with DLA-D-locus-encoded antigens by canine cytotoxic lymphocytes. Transplantation 40:323–328
Ross P, Buntzman AS, Vincent BG, Grover EN, Gojanovich GS, Collins EJ, Frelinger JA, Hess PR (2012) Allelic diversity at the DLA-88 locus in Golden Retriever and Boxer breeds is limited. Tissue Antigens 80:175–183
Sarmiento UM, Storb R (1990) Nucleotide sequence of a dog DRB cDNA clone. Immunogenetics 31:396–399
Sarmiento UM, DeRose S, Sarmiento JI, Storb R (1992) Allelic variation in the DQ subregion of the canine major histocompatibility complex: I. Immunogenetics 35:416–420
Sarmiento UM, DeRose S, Sarmiento JI, Storb R (1993) Allelic variation in the DQ subregion of the canine major histocompatibility complex: II. Immunogenetics 37:148–152
Schu S, Nosov M, O’Flynn L, Shaw G, Treacy O, Barry F, Murphy M, O’Brien T, Ritter T (2012) Immunogenicity of allogeneic mesenchymal stem cells. J Cell Mol Med 16:2094–2103
Screven R, Kenyon E, Myers MJ, Yancy HF, Skasko M, Boxer L, Bigley EC III, Borjesson DL, Zhu M (2014) Immunophenotype and gene expression profile of mesenchymal stem cells derived from canine adipose tissue and bone marrow. Vet Immunol Immunopathol 161:21–31
Shiba Y, Gomibuchi T, Seto T, Wada Y, Ichimura H, Tanaka Y, Ogasawara T, Okada K, Shiba N, Sakamoto K, Ido D, Shiina T, Ohkura M, Nakai J, Uno N, Kazuki Y, Oshimura M, Minami I, Ikeda U (2016) Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts. Nature 538:388–391
Shiina T, Hosomichi K, Inoko H, Kulski JK (2009) The HLA genomic loci map: expression, interaction, diversity and disease. J Hum Genet 54:15
Silva GV, Litovsky S, Assad JA, Sousa AL, Martin BJ, Vela D, Coulter SC, Lin J, Ober J, Vaughn WK, Branco RV, Oliveira EM, He R, Geng YJ, Willerson JT, Perin EC (2005) Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 111:150–156
Stagg J, Pommey S, Eliopoulos N, Galipeau J (2006) Interferon-γ-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell. Blood 107:2570–2577
Stephens M, Smith NJ, Donnelly P (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978–989
Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Strominger JL, Wiley DC (1994) Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215–221
Suchin EJ, Langmuir PB, Palmer E, Sayegh MH, Wells AD, Turka LA (2001) Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J Immunol 166:973–981
Tanaka Y, Ohdan H, Onoe T, Asahara T (2004) Multiparameter flow cytometric approach for simultaneous evaluation of proliferation and cytokine-secreting activity in T cells responding to allo-stimulation. Immunol Investig 33:309–324
Tanaka Y, Ohdan H, Onoe T, Mitsuta H, Tashiro H, Itamoto T, Asahara T (2005) Low incidence of acute rejection after living-donor liver transplantation: immunologic analyses by mixed lymphocyte reaction using a carboxyfluorescein diacetate succinimidyl ester labeling technique. Transplantation 79:1262–1267
Van Oers M, Pinkster J, Zeijlemaker W (1978) Quantification of antigen-reactive cells among human T lymphocytes. Eur J Immunol 8:477–484
Venkataraman GM, Geraghty D, Fox J, Graves SS, Zellmer E, Storer BE, Torok-Storb BJ, Storb R (2013) Canine DLA-79 gene: an improved typing method, identification of new alleles and its role in graft rejection and graft-versus-host disease. Tissue Antigens 81:204–211
Venkataraman GM, Kennedy LJ, Little ME, Graves SS, Harkey MA, Torok-Storb BJ, Storb R (2017) Thirteen novel canine dog leukocyte antigen-88 alleles identified by sequence-based typing. HLA 90:165–170
Wagner J, Sarmiento U, Storb R (2002) Cellular, serological, and molecular polymorphism of the class I and class II loci of the canine major histocompatibility complex. Tissue Antigens 59:205–210
Wells AD, Gudmundsdottir H, Turka LA (1997) Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J Clin Invest 100:3173–3183
Wilson DB, Blyth JNP (1968) Quantitative studies on the mixed lymphocyte interaction in rats. 3. Kinetics of the response. J Exp Med 128:1157–1181
Zhang Q, Cecka JM, Gjertson DW, Ge P, Rose ML, Patel JK, Ardehali A, Kobashigawa JA, Fishbein MC, Reed EF (2011) HLA and MICA: targets of antibody-mediated rejection in heart transplantation. Transplantation 91:1153
Acknowledgments
We would like to thank Dr. Kiyoshi Sakata, Dr. Ichiro Hirahara, and Dr. Hideki Satou, Terumo Corporation R&D Center (Japan), for supporting funding and sampling for this work.
Funding
This work was supported by the Sasakawa Scientific Research Grant from The Japan Science Society (2018-4052) and a grant of International joint research and training of young researchers for zoonosis control in the globalized world (S1491007) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) Japan.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors report no potential conflicts of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary materials
Supplementary Fig. 1
Each primer location for the determination of (A) DLA-DRB1, (B) -DQA1, and (C) -DQB1 cDNA allele sequences. Each primer location is highlighted with an underline and the primer name is described below the line. Each coding sequence is highlighted with a green background. The information on each DLA class II sequence shown in the figure is as follows: DLA-DRB1 (Accession No. M29611), DLA-DQA1 (Accession No. NM_001011726), and DLA-DQB1 (Accession No. AH006318). SP: Signal peptide, TM: Transmembrane region, CY: Cytoplasmic region (DOCX 147 kb)
Supplementary Fig. 2
Inheritance of DLA haplotypes based on cDNA analysis in four beagle families. A total of 38 beagles from four families were used for obtaining haplotype information including five DLA loci. Colored bars show the DLA haplotypes that are indicated in the table below the four pedigree charts (PPTX 108 kb)
Supplementary Fig. 3
Method for quantifying alloreactive T cell proliferation in CytoTell-based MLR assay. After finishing MLR culture, a CytoTell fluorescent histogram of CD3+, CD3+CD4+, or CD3+CD8+ T cell populations was created to represent the history of T cell proliferation upon reacting to allo-antigens. Each gate on the CytoTell fluorescent histogram was constructed in accordance with the CytoTell fluorescent intensity decreasing by half from the highest intensity peak. Each cell division round was labeled based on each gate from 0 to n. The number of daughter T cells (Nc) was obtained from the flow cytometer. The number of precursor cells (Npc) was calculated by dividing the number of daughter cells in each gate by 2n. Total number of proliferation events was obtained by subtracting the total of precursor T cells from the total of daughter T cells. The proliferation indices (PI) were calculated by dividing the total number of precursors by proliferation events. Precursor frequency was calculated by dividing the total of precursor T cells that had divided once or more (sum of Npc1 to Npc8) by the total of all precursors including non-dividing ones (sum of Npc0 to Npc8) (PPTX 79 kb)
Supplementary Fig. 4
Comparisons of estimated amino acid sequences and protein structure between DLA-DRB1*001:01 and DLA-DRB1*001:02. (A) Alignment of estimated amino acid sequences in exon 2. Dots indicate matched sites with the HLA-DRB1 sequence, and a red colored background indicates the different residue between two DLA-DRB1 alleles at position 47. (B) Estimated protein structures of DLA-DRB1*001:01, DLA-DRB1*001:02, and HLA-DRB1*01:01:01. Green and purple colors indicate β-sheet and α-helix structures, respectively. Carbon skeletons at position 47 are shown in each structure. Red circle in the HLA-DRB1*01:01:01 structure represents an approximate location of peptide-binding site pocket 7 (Stern et al. 1994) (PPTX 1460 kb)
Supplementary Table 1
(XLSX 11 kb)
Supplementary Table 2
(XLSX 13 kb)
Supplementary Table 3
(XLSX 42 kb)
Rights and permissions
About this article
Cite this article
Miyamae, J., Yagi, H., Sato, K. et al. Evaluation of alloreactive T cells based on the degree of MHC incompatibility using flow cytometric mixed lymphocyte reaction assay in dogs. Immunogenetics 71, 635–645 (2019). https://doi.org/10.1007/s00251-019-01147-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00251-019-01147-4